› $150,000,000 verdict in personal injury case
Telaprevir, a new treatment for hepatitis C by Vertex Pharmaceuticals, is showing positive results from a late-stage study, boosting company shares. But TheStreet.com warns that despite the promising results, the treatment has issues that may be making investors cautious, including a link to the serious allergic reaction Stevens Johnson Syndrome (SJS).
When Nichole Chapman, of Klamath Falls, Ore., was just 6 years old, she developed a severe skin rash that doctors diagnosed as a bad case of measles. But the rash turned into huge blisters and soon Nichole’s skin was peeling off her tiny body. Doctors began to realize that it wasn’t measles that was eating away at Nichole’s skin, it was a rare and potentially life threatening allergic reaction to medication known as Stevens Johnson Syndrome, or SJS.
